Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.955 USD | -1.89% | -4.12% | +21.57% |
17/05 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
13/05 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.57% | 19Cr | |
+12.14% | 12TCr | |
+12.58% | 11TCr | |
-9.30% | 2.39TCr | |
-1.69% | 2.16TCr | |
-10.60% | 1.9TCr | |
-41.25% | 1.7TCr | |
-15.45% | 1.63TCr | |
+6.10% | 1.41TCr | |
+28.97% | 1.2TCr |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc. - Special Call